HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryouichi Horie Selected Research

Lung Neoplasms (Lung Cancer)

2/2014Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells.
12/2009Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryouichi Horie Research Topics

Disease

15Hodgkin Disease (Hodgkin's Disease)
06/2021 - 04/2002
12Neoplasms (Cancer)
01/2020 - 04/2002
6Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2007 - 05/2005
5Lymphoma (Lymphomas)
03/2011 - 05/2002
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2017 - 04/2004
4T-Cell Leukemia (Leukemia, T Cell)
11/2007 - 10/2005
3Thrombocytopenia (Thrombopenia)
12/2023 - 01/2021
2Chromosomal Instability (Chromosome Stability)
08/2023 - 04/2023
2Liver Diseases (Liver Disease)
01/2021 - 12/2018
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 01/2009
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 01/2013
2Lung Neoplasms (Lung Cancer)
02/2014 - 12/2009
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2010 - 11/2002
2Multiple Myeloma
03/2005 - 07/2004
1Chronic Hepatitis C
12/2023
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2022
1Hypoxia (Hypoxemia)
06/2021
1Inflammation (Inflammations)
09/2019
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2015
1Adenocarcinoma of Lung
02/2014
1Melanoma (Melanoma, Malignant)
01/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2012
1Diabetes Mellitus
09/2011
1Infections
03/2011
1Hepatitis B
03/2011
1Hepatitis
03/2011
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
09/2010
1Giardiasis
09/2010
1Disease Progression
01/2010
1Plasmablastic Lymphoma
01/2010
1Stomach Neoplasms (Stomach Cancer)
12/2009
1Oncogene Addiction
12/2009
1Colonic Neoplasms (Colon Cancer)
12/2009
1Jaundice (Icterus)
06/2007
1Splenic Infarction
06/2007
1Residual Neoplasm
04/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2007
1Carcinogenesis
01/2006
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
08/2005

Drug/Important Bio-Agent (IBA)

19NF-kappa B (NF-kB)IBA
01/2011 - 04/2002
4Anaplastic Lymphoma KinaseIBA
01/2017 - 04/2004
4dehydroxymethylepoxyquinomicinIBA
01/2013 - 08/2005
3DNA (Deoxyribonucleic Acid)IBA
04/2023 - 08/2005
3Transcription Factors (Transcription Factor)IBA
01/2013 - 08/2005
2AutoantibodiesIBA
12/2023 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2023 - 06/2021
2lusutrombopagIBA
01/2021 - 12/2018
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2013
2Surface Antigens (Surface Antigen)IBA
03/2011 - 08/2005
2Tumor Biomarkers (Tumor Markers)IBA
08/2005 - 07/2004
1Antiviral Agents (Antivirals)IBA
12/2023
1ChromatinIBA
08/2023
1Inosine Triphosphate (ITP)IBA
11/2022
1AntibodiesIBA
11/2022
1Glycoproteins (Glycoprotein)IBA
11/2022
1Platelet Membrane Glycoprotein IIbIBA
11/2022
1B-Cell Activating FactorIBA
11/2022
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2021
1Heme Oxygenase-1IBA
06/2021
1Thrombopoietin (c-mpl Ligand)IBA
01/2021
1CytokinesIBA
09/2019
1CD30 LigandIBA
05/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1JNK Mitogen-Activated Protein KinasesIBA
01/2017
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017
1Edetic Acid (EDTA)FDA Link
12/2015
1Brefeldin AIBA
09/2015
1Mechanistic Target of Rapamycin Complex 1IBA
02/2014
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
02/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2014
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2013
1Azacitidine (5 Azacytidine)FDA Link
01/2012
1Sorbitol (Yal)FDA Link
09/2011
1Glycated Serum AlbuminIBA
09/2011
1Rituximab (Mabthera)FDA Link
03/2011
1LigandsIBA
01/2011
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2010
1Metronidazole (Metric)FDA LinkGeneric
09/2010
1ParaffinIBA
01/2010
1Formaldehyde (Formol)FDA Link
01/2010
1I-kappa B KinaseIBA
12/2009
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
12/2009
1CamptothecinIBA
12/2009
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2008
1Imatinib Mesylate (Gleevec)FDA Link
04/2007
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2006
1Mitogen-Activated Protein KinasesIBA
09/2005
1NucleophosminIBA
09/2005
1Phosphotransferases (Kinase)IBA
09/2005
1Interleukin-6 (Interleukin 6)IBA
08/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2004

Therapy/Procedure

5Drug Therapy (Chemotherapy)
12/2009 - 11/2002
4Therapeutics
01/2013 - 10/2005
2Radiotherapy
01/2010 - 11/2002
2Splenectomy
01/2009 - 06/2007
1Ligation
05/2018
1Patient Admission (Patient Admissions)
06/2007
1Stem Cell Transplantation
04/2007
1Chemoprevention
10/2005